Agarwal, S., & Mehta, S. (2024). Food and drug administration gives breakthrough: sanctioning of Rezdiffra for non-alcoholic steatohepatitis. International Journal of Advances in Medicine, 12(1), 155–155. https://doi.org/10.18203/2349-3933.ijam20243826